Core Viewpoint - IBM shares experienced a significant decline due to concerns that AI advancements, particularly Anthropic's "Claude Code," could undermine its established position in COBOL systems, which are vital for insurance, banking, and government sectors [1] Group 1: Stock Performance and Analyst Recommendations - IBM shares have dropped as much as 28% in February amid a broader software market downturn referred to as "SaaS-mageddon" [1] - Evercore ISI's senior analyst Amit Daryanani views the recent selloff as a buying opportunity, maintaining an "Outperform" rating and highlighting the irreplaceability of IBM's mainframe systems [2] - Daryanani has set a price target of $345 for IBM, indicating a potential upside of 50% by year-end [3] Group 2: Technological Advancements and Market Position - The z17 hardware cycle is outperforming the previous z16 rollout, indicating that mission-critical clients prefer modernization over migration [3] - IBM's integration of watsonx for legacy code and local AI inferencing has transformed its mainframe into a modern AI powerhouse, providing stability and a regulatory-compliant foundation [4] Group 3: Investment Attractiveness - IBM's relative strength index is in the deeply oversold territory, suggesting a potential relief rally in the near term [5] - The company offers a lucrative 2.93% dividend yield, enhancing its attractiveness for long-term investors [5] - Other Wall Street analysts concur with Daryanani, suggesting that the recent selloff of IBM shares may have been excessive [6]